5.19
Finanzdaten der Compass Therapeutics Inc-Aktie (CMPX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
|
|
13.74%
17.99
|
15.82 | 21.07 | 17.97 | 12.24 |
| Depreciation and Amortization |
10.53%
0.017
|
0.019 | 0.10 | 0.14 | 0.143 |
| Operating Income/Loss |
13.74%
-17.99
|
-15.82 | -21.07 | -17.97 | -12.24 |
| Income/Loss From Continuing Operations Before Tax |
10.22%
-15.72
|
-14.26 | -19.88 | -16.63 | -10.48 |
| Income/Loss From Continuing Operations After Tax |
10.22%
-15.72
|
-14.26 | -19.88 | -16.63 | -10.48 |
|
|
10.22%
-15.72
|
-14.26 | -19.88 | -16.63 | -10.48 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
94.58%
9.15
|
168.78 | 138.28 | 138.24 | 137.59 |
| Basic Earnings Per Share |
0.00%
-0.08
|
-0.08 | -0.14 | -0.12 | -0.08 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):